Anne Moulin
President, Dômes Pharma US
+ President @ DOMES PHARMA US Inc.
+ Member of the Executive Board
Anne Moulin graduated from the Institut Supérieur de Gestion in Paris in International Business and has an MBA from the SDA BOCCONI School of Management in Milan (2007).
In 2003 she chose to bring her skills to the family business.
Initially Anne started as Management Controller in Factoria, and after a period in the GRUNENTHAL Lab in Milan, she served successively as Executive Director in different subsidiaries, Veto-Centre (now Domes Pharma FR Pharmacy division), TVM Lab (now Dômes Pharma FR Vet division) and Europhartech (CDMO).
In 2012, at 32 years old, she commenced in the position of Executive Director with aims to prepare the DOMES PHARMA Group to address its third great evolution: digitalization and internationalization.
In 2016, she is appointed C.E.O., after Chantal Lugnier, co-founder of the DOMES PHARMA Group.
Under her leadership, the Group has acquired Wanimo.com (2012), LERO Lab(2015), FORUM Animal Health UK (2016) and founded Domes Pharma Tiergesundheit (2020), and Dômes Pharma US Inc since 2022. She is actively leading the business development of DOMES PHARMA veterinary expertise in Ophthalmology, Antitox and Neurology- Epilepsy across Europe and North America.
In parallel, a reorganization of trades and skills within the subsidiaries resulted in a rationalization of human and material resources and leads to a perfect complementarity between the different entities. In this scheme, the holding company actively participates in the conduct of the Group's strategy by providing an important panel of resources to its subsidiaries.
At the age of 42, the granddaughter of Simone Moulin, creator of the Biocanina brand and daughter of Jean Moulin, co-founder of the Group and of TVM (in association with Chantal Lugnier, previous C.E.O, today member of the Supervisory Board), ensures the destiny of an independent family group of 400 employees, with a consolidated turnover exceeding 80 million euros.
